Average Co-Inventor Count = 5.98
ph-index = 19
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Bristol-myers Squibb Compnay (51 from 3,685 patents)
2. Ligand Pharmaceuticals, Inc. (12 from 134 patents)
3. Other (1 from 832,891 patents)
4. University of California (1 from 15,488 patents)
5. Bristol Meyers Squibb Company (1 from 41 patents)
6. Astrazeneca Ab (1,500 patents)
7. Viiv Healthcare UK Limited (9 patents)
8. Bristol-myers Squibb Holdings Ireland (0 patent)
65 patents:
1. 9758487 - Hepatitis C virus inhibitors
2. 9227961 - Hepatitis C virus inhibitors
3. 9193725 - Cyclic hydrazine derivatives as HIV attachment inhibitors
4. 9018390 - Hepatitis C virus inhibitors
5. 8846023 - Hepatitis C virus inhibitors
6. 8822444 - Hepatitis C virus inhibitors
7. 8809548 - Hepatitis C virus inhibitors
8. 8685982 - Thioamide, amidoxime and amidrazone derivatives as HIV attachment inhibitors
9. 8642025 - Hepatitis C virus inhibitors
10. 8574563 - Hepatitis C virus inhibitors
11. 8546394 - Substituted [1,2,4]triazolo[4,3-A]pyrazine 11-beta-hydroxysteroid dehydrogenase inhibitors
12. 8492553 - Hepatitis C virus inhibitors
13. RE44186 - Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method
14. 8303944 - Hepatitis C virus inhibitors
15. 8288562 - Hepatitis C virus inhibitors